[1] |
XIE Rui, GENG Zihan, BAO Lei, ZHAO Ronghua, LI Shuran, SUN Qiyue, WANG Xinwei, ZHANG Jingsheng, CUI Xiaolan, GUO Shanshan, SUN Jing.
Research Progress in Pharmacological Actions, Mechanisms, Structural Modifications and Targeted Formulations of Ribavirin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 950-955.
|
[2] |
LIU Ming, ZHENG Li, ZHANG Weina, SUN Xuelin, TIAN Jinhui, ZHAO Yan.
Research Progress in Biological Activity and Mechanisms of Pachymic Acid
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 826-830.
|
[3] |
YE Ling, LIU Xiaoying, DANG Xuefei, LI Xuelian, LI Gang.
Research Progress in Drugs for Brain Metastases from Advanced Breast Cancer
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 714-720.
|
[4] |
LIU Chang, SHI Chang, YIN Jiye.
Nonclinical immunotoxicity evaluation of CAR-T cell products
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1051-1055.
|
[5] |
CAI Haili, ZHANG Xiaomeng, LIU Yadi, LIU Shujia, GAO Fujun, WANG Yu, ZHANG Bing.
Progress in construction and evaluation of a drug-induced cardiotoxicity model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 765-770.
|
[6] |
LI Wenpeng, LIU Mingyu, CAO Ying, ZHOU Huziwei, WANG Shengfeng.
Supervision status and research progress of global abuse of opioids
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 513-518.
|
[7] |
SUN Qiyue, GUO Shanshan, ZHAO Ronghua, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Research progress on animal models of allergic rhinitis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 241-245.
|
[8] |
LIU Sujie, YAN Jiahe, RUAN Jiaxin, WANG Chen, WANG Xiaofan, LIU Shumin, BAI Xue.
Research Progress in Regulation of Wnt/β-Catenin Signaling Pathway by TCM in the Treatment of Ischemic Stroke
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1388-1392.
|
[9] |
BAI Xue, CHEN Yafei, TANG Tian, LIU Zhejun, TAN Tianyang, LIU Zhenquan.
Research Progress on the Potential Therapeutic Effect of Bushen Shengjing Prescription on Oligoasthenozoospermia
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1243-1249.
|
[10] |
LUO Qiong, LI Meng, LI Guangyao, HE Yanchun, ZHOU Zushan, SUN Xin, LIU Chenghai.
Chinese medical evidence and characteristics of combined medication in 635 cases of rheumatoid arthritis patients with liver injury caused by the application of Tripterygium wilfordii preparations
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 500-504.
|
[11] |
BAO Lei, GENG Zihan, GUO Shanshan, YAO Rongmei, SUN Jing, CUI Xiaolan.
Effect of Reyanning Heji on animal models of respiratory infectious inflammation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 241-247.
|
[12] |
WANG Shan, HUANG Jukai, WU Honghui, WEN Yalu, ZHANG Li, WANG Jianhua, YANG Xiaohui.
Evaluation of a KKAy animal model of type 2 diabetes mellitus combined with nonalcoholic fatty liver disease
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 273-276.
|
[13] |
FU Changli, LU Yuan, CHEN Siying, WANG Yonglin, LI Yongjun, WANG Aimin, LIU Chunhua.
Mechanisms of Laportea bulbifera against rheumatoid arthritis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 171-176.
|
[14] |
GAO Jing, ZHANG Zhuo, YAN Jiayi, GE Yunxuan, MA Zengchun, GAO Yue.
Evaluation of animal models of high altitude qi deficiency and blood stasis syndrome and research progress in therapeutic drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1189-1194.
|
[15] |
PANG Bo, ZHANG Jingsheng, GUO Shanshan, SUN Jing, BAO Lei, XU Yingli, CAO Shan, CHEN Mengping, WANG Yaxin, ZHAO Ronghua, CUI Xiaolan.
Establishment and evaluation of a mouse model combining disease with syndrome of HCoV-229E pneumonia with lung-attacking damp-heat syndrome
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 40-45.
|